Converge Bio has raised $5.5 million in seed funding led by TLV Partners.WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs…
What You Should Know:
– Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
– Converge Bio’s platform uses large language…
Continue Reading
Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance programs and prescription drugs.
Experts interviewed for…
Continue Reading
Former President Donald Trump’s return to the White House will undoubtedly bring about changes in the healthcare world — most likely in the forms of scaling back federally funded insurance programs like Medicaid and…
Continue Reading
DarioHealth, a digital chronic condition management platform, announced a collaboration with an unnamed pharma company that will leverage DarioConnect (formerly Twill Care) to advance its direct-to-consumer initiatives using Dario’s engagement and navigation technologies.The aim…
Continue Reading
What You Should Know:
– Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, has launched ProPhet, a startup using artificial intelligence to locate small molecules for drug discovery.ProPhet was established following AION Labs’…
Continue Reading
Pharmaceutical company Tolmar has partnered with direct-to-consumer telehealth company UpScriptHealth to provide telehealth consultations for Jatenzo, an oral testosterone-replacement therapy (TRT) for adult men.Tolmar, which acquired Jatenzo in 2022, is positioning the TRT treatment…
Continue Reading
The first day of the HLTH2024 event is done and boy what a conference it has been so far!The diversity of speakers and attendees has been off-the-charts. Payers, providers, pharma, patients, medical device makers,…
Continue Reading
Christopher Wooden, Senior Director, Business Marketing, IQVIA
A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs)….
Continue Reading
